Navigation Links
10th Functional Genomics: Chemical Biology 2009
Date:8/21/2009

A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.

In the field of chemical biology, chemists and biologists cooperate to investigate, and eventually control, the behavior of cells. The scientists use small molecules that activate certain proteins to study how cells communicate, and ultimately they want to be able to prevent disease-causing interactions and understand how medicines and environmental toxins work on a cellular level.

The potential applications of research in chemical biology are unlimited. A number of serious diseases that lack effective treatments are currently being studied. Many of them will be discussed on 24-25 August when the University of Gothenburg and Chalmers University of Technology host the Functional Genomics/Chemical Biology conference in Gothenburg, Sweden:

  • Professor Carsten Schultz from the European Molecular Biology Laboratory (EMBL) in Heidelberg is developing new tools that will help us better understand cystic fibrosis. By visualising how cell signaling goes awry, Schultz hopes to come closer to finding a treatment for the incurable disease.

  • Ronald Raines from the University of Wisconsin has designed a 'Trojan horse' - an enzyme that infiltrates and then attacks the viruses that cause HIV and the lung disease SARS.

  • Guri Giaever from the University of Toronto uses yeast to investigate the action mechanism of medicines. Giaver is working together with pharmaceutical companies to explore and eliminate side effects of medicines.

  • Henrik Pavia is a University of Gothenburg marine ecologist and an expert in how marine organisms produce and utilise chemical substances. At the conference, Pavia will share the latest knowledge on how these marine bioactive substances can be used to create medicines for humans.

The conference, held at the Chalmers Conference Centre, will also present new findings about environmental toxins and the research currently carried out to identify how molecules in the cell are affected by the toxins.


'/>"/>

Contact: Per Sunnerhagen
per.sunnerhagen@cmb.gu.se
46-070-529-4180
University of Gothenburg
Source:Eurekalert

Related biology news :

1. Researchers expand efforts to explore functional landscape of the human genome
2. The endocannabinoids: Functional roles and therapeutic opportunities
3. RevGenUK, a single-stop shop for use in functional genomics
4. Junk DNA proves functional
5. Researchers generate functional neurons from somatic cells
6. ADA releases updated position statement on functional foods
7. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
8. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
9. Thermochemical process converts poultry litter into bio-oil
10. New chemically-sensitive MRI scan may bypass some invasive diagnostic tests in next decade
11. Natural chemical found in broccoli helps combat skin blistering disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology: